NK-IB02 transcranial magnetic stimulator designed for clinical neuromodulation using repetitive transcranial magnetic stimulation (rTMS) combined with simulated biological electrical stimulation of the cerebellar fastigial nucleus.
Applies synchronized magnetic and electrical stimulation to modulate cerebral blood vessels, microcirculation and neural activity.
Clinical indications
Intended for use in neurology, neurosurgery, rehabilitation and psychiatry departments for therapeutic neuromodulation and rehabilitation support.
Suitable for hospitals and clinics at county level and above, including private hospitals.
Working principle
Delivers patterned repetitive transcranial magnetic stimulation (rTMS) via a dedicated therapeutic generator (alternating electromagnetic field of negative polarity).
Combined with simulated biological electrical stimulation targeting the cerebellar fastigial nucleus to enhance neuromodulatory effects.
Physiological effects described include: increase cerebral vascular elasticity; improve blood circulation in lesion areas; improve metabolic environment of brain tissue; guide normalization and ordering of EEG and brain magnetic activity.
Technical specifications
Dimensions: 125 cm × 150 cm × 210 cm.
Therapy modes: rTMS protocols with adjustable frequency, intensity and pulse parameters; simulated cerebellar electrical stimulation.
Clinical interface: configurable treatment programs, safety interlocks and monitoring outputs.
Configuration
Main unit: rTMS treatment unit ×1.
Accessory: simulated biological electrical stimulator for cerebellar fastigial nucleus ×1.
Target customers and departments
Sales targets: private hospitals, county-level and higher medical institutions.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.